Apremilast for a psoriasis patient with HIV and hepatitis C.
SP Reddy, VV Shah, JJ Wu - Journal of the European …, 2017 - search.ebscohost.com
SP Reddy, VV Shah, JJ Wu
Journal of the European Academy of Dermatology & Venereology, 2017•search.ebscohost.comThe article presents a case study of a 46-year old male with HIV, hepatitis C and moderate
psoriasis was resistant to starting ultra violet B phototherapy due to scheduling issues. The
psoriasis in a patient with both HIV and hepatitis C successfully treated with apremilast and
psoriasis in the human immunodeficiency virus (HIV)-infected population often pose a
challenge. It mentions secretion of inflammatory cytokines such as tumour necrosis factor
(TNF).
psoriasis was resistant to starting ultra violet B phototherapy due to scheduling issues. The
psoriasis in a patient with both HIV and hepatitis C successfully treated with apremilast and
psoriasis in the human immunodeficiency virus (HIV)-infected population often pose a
challenge. It mentions secretion of inflammatory cytokines such as tumour necrosis factor
(TNF).
Abstract
The article presents a case study of a 46-year old male with HIV, hepatitis C and moderate psoriasis was resistant to starting ultra violet B phototherapy due to scheduling issues. The psoriasis in a patient with both HIV and hepatitis C successfully treated with apremilast and psoriasis in the human immunodeficiency virus (HIV)-infected population often pose a challenge. It mentions secretion of inflammatory cytokines such as tumour necrosis factor (TNF).
search.ebscohost.com
以上显示的是最相近的搜索结果。 查看全部搜索结果